Aogi, Kenjiro
SHOWA Medical University · Memorial Sloan Kettering Cancer Center · Vall d'Hebron Hospital Universitari · The Cancer Institute Hospital · Shikoku Cancer Center · Japanese Foundation For Cancer Research · Kanagawa Cancer Center · Vall d'Hebron Institute of Oncology · National Cancer Center Hospital
2 papers on CoChatORCID 0000-0001-6512-7051
Most cited papers
- Verified
Trastuzumab deruxtecan in previously treated HER2-positive breast cancer
Modi, S., Saura, C., Yamashita, T., Park, Y. H., Kim, S.-B., Tamura, K., Andre, F., Iwata, H., Ito, Y., Tsurutani, J., et al. (2020) · New England Journal of Medicine
HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations
Cited by 2,006
- Verified
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Swain, S. M., Miles, D., Kim, S.-B., Im, Y.-H., Im, S.-A., Semiglazov, V., Ciruelos, E., Schneeweiss, A., Loi, S., Monturus, E., et al. (2020) · The Lancet Oncology
HER2/EGFR in Cancer ResearchGastric Cancer Management and Outcomes
Cited by 922
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free